Sirolimus for Nosebleeds in HHT

Hereditary hemorrhagic telangiectasia

Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era. Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, in Response to BMP9 for the Identification of New Therapeutic Targets in Hereditary Haemorrhagic Telangiectasia Assess Safety and Efficacy of VAD044 in HHT Patients Sirolimus for Nosebleeds in HHT Tacrolimus Crossover Trial for Hereditary Hemorrhagic Telangiectasia (HHT) Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia Bevacizumab In Hereditary Hemorrhagic Telangiectasia Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding Intranasal Bevacizumab for HHT-Related Epistaxis Evaluation of Video-assisted Instructions of Nasal Self-packing in Patients With HHT Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept Frequency of Common Medical Conditions in People With and Without HHT Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial Iron Deficiency and Hereditary Haemorrhagic Telangiectasia Vitamin D and Hereditary Haemorrhagic Telangiectasia Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia Diet and Hereditary Haemorrhagic Telangiectasia MRA With Feraheme in HHT Hereditary Haemorrhagic Telangiectasia Flight Safety Study Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia Patients Hereditary Hemorrhagic Telangiectasia (HHT) Research Outcomes Registry Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients Development of a Quality of Life Measurement Scale in Hereditary Haemorrhagic Telangiectasia (HHT) Disease. Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT) Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia Pazopanib Effects on Bleeding in Hereditary Hemorrhagic Telangiectasia Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) Doxycycline for Hereditary Hemorrhagic Telangiectasia Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) Recurrence of Hereditary Hemorrhagic Telangiectasia (HHT) After Liver Transplantation